[68Ga]Ga-DOTA-TATE clinical trials
3 indexed studies · 0 currently recruiting
- Active not recruitingPHASE1, PHASE2
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
This study is testing a new combination treatment for a type of lung cancer called Extensive Stage Small Cell Lung Cancer (ES-SCLC). It aims to find a safe dose and see if this new combination works better than current treatments for people newly diagnosed with this aggressive cancer.
For: Extensive Stage Small Cell Lung CancerUnited States · Austria · Canada - Active not recruitingPHASE1
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
This study looks at a new treatment called [177Lu]Lu-DOTA-TATE for glioblastoma, a type of brain tumour. It's testing different doses and how well it works, both on its own and with usual treatments, in people recently diagnosed or whose cancer has come back.
For: GlioblastomaUnited States · France · Portugal - Active not recruitingPHASE1
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
This study looks at new ways to treat prostate cancer that has spread. It uses special scans to find cancer cells and then delivers targeted radiation therapy to those cells, aiming to see how well it works and if it's safe.
For: Metastatic Neuroendocrine Prostate CancerUnited States · France · Germany